The paradoxical role of matrix metalloproteinase-11 in cancer

Bing Ma,Rui Ran,Hai-Yang Liao,Hai-Hong Zhang
DOI: https://doi.org/10.1016/j.biopha.2021.111899
2021-09-01
Abstract:The microenvironment surrounding the tumor affects biological processes, such as cell proliferation, angiogenesis, apoptosis, and invasion. Therefore, the ability to change these environments is an important attribute for tumor cells to obtain specific functions necessary for growth and metastasis. Matrix metalloproteinases (MMPs) are zinc-dependent proteolytic metalloenzymes that facilitate protease-dependent tumor progression by degrading extracellular matrix (ECM) proteins, releasing cytokines, growth factors, and other cell surface molecules. As one of the most widely studied MMPs, MMP-11 is an important protease that is expressed in cancer cells, stromal cells, and the adjacent microenvironment. MMP-11 has a dual effect on tumors. On one hand, MMP-11 promotes tumor development by inhibiting apoptosis and promoting the migration and invasion of cancer cells in the early stage. On the other hand, in animal models, MMP-11 has a protective effect on tumor growth and metastasis at an advanced stage. Based on current findings regarding the importance of MMP-11 in altering the tumor microenvironment, there is a need to further understand how stromal cells and the ECM regulate tumor progression, which may result in the re-examination of MMPs as drug targets for cancer and other diseases. In this review, we summarize the dual role of MMP-11 in cancer and its potential clinical significance.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?
This paper attempts to explore the paradoxical role of matrix metalloproteinase - 11 (MMP - 11) in cancer and its potential clinical significance. Specifically, the paper focuses on how MMP - 11 affects tumor development and metastasis by altering the tumor microenvironment. MMP - 11 promotes tumor development in the early stage by inhibiting apoptosis and promoting the migration and invasion of cancer cells; while in the late stage, MMP - 11 shows a protective effect on tumor growth and metastasis in animal models. Therefore, the paper aims to further understand how stromal cells and extracellular matrix (ECM) regulate tumor progression, which may require a re - evaluation of the possibility of MMPs as drug targets for cancer and other diseases. By reviewing the role of MMP - 11 in different types of cancers, including breast cancer, gastric cancer, colorectal cancer, pancreatic cancer, cervical cancer, hepatocellular carcinoma, prostate cancer, and head - and - neck cancer, etc., the paper analyzes in detail the expression of MMP - 11 in these cancers and its relationship with tumorigenesis, development, invasion, and metastasis. In addition, the paper also discusses the dual - action mechanism of MMP - 11, that is, it can both promote and inhibit tumor development under different conditions, which is of great significance for understanding the potential value of MMP - 11 in cancer treatment.